Jiangdian Wang
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
Papers in
- Oncology 5
- Cancer Immunotherapy and Biomarkers 5
- Pancreatic and Hepatic Oncology Research 1
-
- Gastric Cancer Management and Outcomes 3
- Co-authors
- Mary J. Savage (4 shared papers)Jared Lunceford (2 shared papers)Debra Hanks (2 shared papers)Kenneth Emancipator (2 shared papers)Karina Kulangara (2 shared papers)Jonathan Juco (2 shared papers)Nancy R. Zhang (1 shared paper)Ellie Corigliano (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Gastric Cancer (1 paper)Clinical Therapeutics (1 paper)Archives of Pathology & Laboratory Medicine (1 paper)Clinical Pharmacology Advances and Applications (1 paper)
- Partner nations
- United StatesSouth KoreaIsrael
In The Last Decade
Jiangdian Wang
12 papers receiving 884 citations
Jiangdian Wang's Hit Papers
Peers
Comparison fields: 5 of 55
- Oncology 558
- Gastroenterology 94
- Pulmonary and Respiratory Medicine 270
- Immunology 143
- Surgery 212
Countries citing papers authored by Jiangdian Wang
This map shows the geographic impact of Jiangdian Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangdian Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangdian Wang more than expected).
Fields of papers citing papers by Jiangdian Wang
This network shows the impact of papers produced by Jiangdian Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangdian Wang. The network helps show where Jiangdian Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiangdian Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer Hit paper breakdown → | 2018 | 394 |
| 2 | 2019 | 194 | |
| 3 | 2017 | 130 | |
| 4 | 2018 | 63 | |
| 5 | 2017 | 55 | |
| 6 | 2017 | 20 | |
| 7 | 2018 | 11 | |
| 8 | 2016 | 9 | |
| 9 | 2014 | 7 | |
| 10 | 2020 | 3 | |
| 11 | Shape restricted nonparametric regression based on multivariate Bernstein polynomials | 2012 | 3 |
| 12 | 2015 | 1 |
About Jiangdian Wang
Jiangdian Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Computational Theory and Mathematics, having authored 12 papers that have together received 890 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Gastric Cancer Management and Outcomes (3 papers), Protein Structure and Dynamics (2 papers), Computational Drug Discovery Methods (2 papers), Advanced Statistical Methods and Models (1 paper), Radiomics and Machine Learning in Medical Imaging (1 paper), Pancreatic and Hepatic Oncology Research (1 paper) and Enzyme Structure and Function (1 paper). The work is most often cited by research in Oncology (558 citations), Gastroenterology (94 citations), Pulmonary and Respiratory Medicine (270 citations), Immunology (143 citations) and Surgery (212 citations). Jiangdian Wang has collaborated with scholars based in United States, South Korea and Israel. Frequent co-authors include Mary J. Savage, Jared Lunceford, Debra Hanks, Kenneth Emancipator, Karina Kulangara, Jonathan Juco, Nancy R. Zhang, Ellie Corigliano, Supriya Shah and Malinka Jansson. Their work appears in journals such as Journal of Clinical Oncology, Gastric Cancer, Clinical Therapeutics, Archives of Pathology & Laboratory Medicine and Clinical Pharmacology Advances and Applications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.